检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:王志敏[1,2] 孙芳玲[1] 刘婷婷[1] 程华[1] 向本旭 魏仁平 艾厚喜[1] 田欣[1] 祝自新[1] 郑文荣[1] 王宇峰[1] 郭德玉[1] 王文[1,3]
机构地区:[1]首都医科大学宣武医院实验动物室、北京市老年病医疗研究中心,北京市100053 [2]曲靖医学高等专科学校,云南曲靖市655000 [3]北京市脑重大疾病研究院,北京市100069
出 处:《中国康复理论与实践》2016年第1期27-31,共5页Chinese Journal of Rehabilitation Theory and Practice
基 金:“重大新药创制”科技重大专项(No.2012ZX09102201-106);国家自然科学基金项目(No.81173575;No.81373994)
摘 要:目的观察莫诺苷对局灶性脑缺血再灌注大鼠皮层CD_(34)表达的影响。方法 45只健康成年雄性Sprague-Dawley大鼠分为假手术组,模型组,莫诺苷小、中、大剂量组,每组9只。线栓法制备大鼠大脑中动脉阻塞30 min后再灌注模型。术后莫诺苷小、中、大剂量组予莫诺苷30 mg/kg、90 mg/kg、270 mg/kg每天灌胃1次。7 d后采用免疫组化(n=6)及Western blotting法(n=3)观察缺血侧皮层CD_(34)表达。结果模型组大鼠患侧皮层CD_(34)表达显著升高,莫诺苷大剂量组较模型组显著升高(F>14.865,P<0.001)。结论莫诺苷可能通过上调局灶性脑缺血再灌注大鼠皮层CD_(34)的表达,促进血管新生。Objective To explore the effects of morroniside on the expression of CD3, in ipsilateral cortex of rats after focal cerebral isch- emia-reperfusion. Methods 45 male Sprague-Dawley rats were divided into sham group (n=9), ischemia group (n=9), and morroniside groups (low, medium and high dosage groups, n=9). The middle cerebral artery were occluded for 30 minutes, and reperfused. Morroniside was administered intragastrically once a day at dose of 30 mg/kg, 90 mg/kg, 270 mg/kg after operation. The expression of CD^4 in the isch- emic ipsilateral cortex were detected with immunohistochemistry (n=6) and Western blotting (n=3) 7 days after operation. Results The ex- pression of CD34 increased in the ischemia group compared with the sham group, and further increased in the morroniside groups of high dos- age compared with the ischemia group (F〉14.865, P〈0.001). Conclusion Morroniside could increase the expression of CD34 in the ischemic ipsilateral cortex after ischemia-reperfusion in rats, which may promote the angiogenesis and neurogenesis after ischemia.
分 类 号:R743.31[医药卫生—神经病学与精神病学]
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.42